Tirzepatide
SHARE
Molecule Summary
| Uses | Type 2 Diabetes Mellitus and Weight Management |
| Therapy | Anti-Diabetic, Anti-Obesity |
| Side Effects | Nausea, Diarrhea, Decreased Appetite, Vomiting, Constipation, Dyspepsia, and Abdominal Pain. |
Assurance
available
Regulated
Molecule Description
Tirzepatide is a prescription medication used to improve blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. It is also indicated for weight management when used in conjunction with a reduced-calorie diet and increased physical activity. While taking Tirzepatide, you may experience common side effects such as nausea, diarrhoea, vomiting, constipation, stomach pain, or indigestion. These effects are usually mild and often improve over time; however, if they become severe or persist, it is advisable to consult your doctor. Importantly, Tirzepatide should not be used if you or your family have a history of a specific type of thyroid cancer called medullary thyroid carcinoma or a condition known as multiple endocrine neoplasia syndrome type 2 (MEN2). Additionally, it is recommended that pregnant individuals or those planning a pregnancy avoid this medication due to potential risks to the baby. Always inform your doctor about all other medications you are taking before starting Tirzepatide to prevent possible interactions.
Uses
Tirzepatide is a prescription medication used to improve blood sugar control in adults with type 2 diabetes when combined with diet and exercise. It is also indicated for weight management when used alongside a reduced-calorie diet and increased physical activity.
Contraindications
When should one not use Tirzepatide
If you are allergic to tirzepatide.
Side effects
Common side effects of this drug are:
- Abdominal pain
- Constipation
- Indigestion
- Nausea
- Diarrhea
- Vomiting
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
Talk to your doctor if
- You have a history of pancreatitis.
- You experience severe abdominal pain, nausea, or vomiting, which could indicate pancreatitis.
Mode of Action
How Does It Work?
Tirzepatide works through a unique dual mechanism of action. It acts as an agonist for both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating these two incretin hormone receptors, Mounjaro facilitates the enhancement of insulin release from the pancreas in a glucose-dependent manner, reduces the amount of glucose produced by the liver, slows gastric emptying, and promotes feelings of fullness, all of which contribute to improved blood sugar control and can aid in weight management.
Interactions
Interactions with other medicines
- Taking oral medications with a narrow therapeutic index, such as warfarin or digoxin, may be affected by tirzepatide, as it can alter their absorption.
- Using medications that require a rapid onset of action might be problematic since tirzepatide may delay their effects.
- Relying on oral contraceptives may be risky, as tirzepatide could reduce their effectiveness. It is advisable to consider switching to a non-oral contraceptive method or to use additional protection for four weeks after starting tirzepatide or increasing its dose.
- Having obesity or being overweight while using oral contraceptives may be concerning since tirzepatide can influence their efficacy.
- Frequent use of paracetamol may be impacted by tirzepatide, as it may delay its absorption; however, no dose adjustment is typically necessary.
Frequently Asked Questions (FAQs)
Articles
View AllDid you find this helpful?
References:
- Farzam K, Patel P. Tirzepatide. [Updated 2024 Feb 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
- Dutta P, Kumar Y, Babu AT, Giri Ravindran S, Salam A, Rai B, Baskar A, Dhawan A, Jomy M. Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond. Cureus. 2023 May 1;15(5):e38379. doi: 10.7759/cureus.38379. PMID: 37265914; PMCID: PMC10231274.
- Lilly.com | Eli Lilly and Company [Internet]. www.lilly.com. [Cited 4 June 2025]
- Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [Cited 4 June 2025]
- MOUNJAROTM (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 [Internet]. uspl.lilly.com.[Cited 4 June 2025]
Explore More at Pharmeasy
Why trust PharmEasy?
# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM
CODAvailable
100%Genuine Medicine
30 DAYReturn Policy









